Comparison of the thromboplastin time measured by using non- anticoagulated whole blood (CoaguChekρPlus) and citrated plasma in patients with or without oral anticoagulation;Vergleich der quick-/INR-werte aus kapillarem vollblut (CoaguChekρPlus) und venosem citratplasma bei patienten mit und ohne orale antikoagulation

Schweizerische Medizinische Wochenschrift

Volumn 128, Issue 44, 1998, Pages 1723-1729

  Burri, S ^a   Demarmels Biasiutti, F ^a   Lammle B ^a   Wuillemin, W A ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; PROTHROMBIN;

ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; HEMOSTASIS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PATIENT MONITORING; THROMBOPLASTIN TIME;

ACENOCOUMAROL; ADULT; AGED; ANTICOAGULANTS; DRUG MONITORING; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINOMETRY; HEPARIN; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIVER DISEASES; MALE; MIDDLE AGED; PHENPROCOUMON; PROTHROMBIN TIME; SENSITIVITY AND SPECIFICITY;

EID: 0032585180     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Vermeer C, Hamuliak K. Pathophysiology of vitamin K-deficiency and oral anticoagulants. Thromb Haemost 1991;66:153-9.
2. Hirsh J. Oral anticoagulant drugs. N Engl J Med 1991; 324:1865-75.
3. Dzung TL, Weibert RT, Sevilla BK, Donelly KJ, Rapaport SI. The international normalized ratio (INR) for monitoring warfarin therapy: reliability and relation to other monitoring methods. Ann Intern Med 1994;120:552-8.
4. Lämmle B, Furlan M, Sulzer I. Vergleich eines sensitiven Kaninchenhirn-Thromboplastins und eines humanen Plazenta-Tromboplastins zur Thromboplastinzeitbestimmung. Schweiz Med Wochenschr 1989;119:178-83.
5. Jennings I, Luddington RJ, Baglin T. Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation. J Clin Pathol 1991;44:950-3.
6. Tripodi A, Arbini AA, Chantarangkul V, Bettega D, Mannucci PM. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio? Thromb Haemost 1993; 70:921-4.
7. Foulis PR, Wallach PM, Adelman HM, Sanford BH, McCain J, Reed D, et al. Performance of the Coumatrak system in a large anticoagulation clinic. Am J Clin Pathol 1995;103: 98-102.
8. Kaatz SS, White RH, Hill J, Mascha E, Humphries JE, Becker DM. Accuracy of laboratory and portable monitor international normalized ratio determinations. Comparison with a criterion standard. Arch Intern Med 1995;155:1861-67.
9. Ansell JE, Patel N, Ostrovsky D, Nozzolillo E, Peterson AM, Fish L. Long-term patient self-management of oral anti-coagulation. Arch Intern Med 1995;155:2185-9.
10. Bernardo A, Bernardo A, Leinberger R, Taborski U, Zerback R. Thromboplastinzeit-Selbstbestimmung mit dem Coagu-Chek®-System. Herz/Kreisl 1995;27:70-5.
11. Wuillemin WA, Burri S, Lämmle B. Quick-Messung aus Kapillar-Blut mittels CoaguChek® oder CoaguChek®Plus. LABOLIFE 1997;3:9-12.
12. McCurdy SA, White RH. Accuracy and precision of a portable anticoagulation monitor in a clinical setting. Arch Intern Med 1992;152:559-89.
13. Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med 1993;153:1441-7.
14. Massicote P, Marzinotto V, Vegh P, Adams M, Andrew M. Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor. J Pediatr 1995; 127:389-94.
15. Ruzicka K, Kapiotis S, Quehenberger P, Handler S, Hornykewycz S, Michitsch A, et al. Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck®Plus in various clinical settings. Thromb Res 1997;87:431-40.
16. Dehara K, Yoshiba M, Inoue K, Sugata F. A simple method for evaluating prothrombin time in severe liver disease. Am J Clin Pathol 1994;101:358-60.